Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by robertshawon Nov 13, 2022 3:08pm
190 Views
Post# 35095151

RE:RE:Crutial 450 day data.

RE:RE:Crutial 450 day data.
N0taP00p wrote:
Thank you, Wildbird for taking the time. Can you or others elaborate a bit on the assumption behind duration of response staying the same? Are you saying once a patient is CR, that patient is likely to maintain CR at future checkpoints? With these 3 cohorts in the data, it can be a little confusing. Also, how much value will the FDA assign to PRs?


Yes, once the patients passed 180 days cancer free, most probably the patients would get 270,360 days cancer free. I still remember the day that the 5th patient of Ph1b get his 270 days, I predicted we should get his 360 days cancer free results also, but Blowjobjoe doubted my prediction and wanted to make a bet with me. Soon, when the day on Jan. 30th, 2019. PMH announced the news of the 5th patient was at 360 days cancer free for only 1 single treatment, Blowjobjoe admited his failure..., and we got the 6th patient 360 days cancer free result on April 2nd, 2019.. Although we won on the science side all these years, but Blowjobjoe's bosses win all the way on manipulation of the share price down there after we get the 1st result of the "cure" patient.
<< Previous
Bullboard Posts
Next >>